Loading…
Cyberliquids, LLC was warned for manufacturing and distributing e-liquid tobacco products without required premarket authorization orders, in violation of the Federal Food, Drug, and Cosmetic Act. The company's website offered e-liquid products containing nicotine for sale in the United States without obtaining FDA approval, which is mandatory for all "new tobacco products" under Section 910 of the FD&C Act. The warning was issued following the March 2022 legislative expansion of FDA jurisdiction to include products containing nicotine from any source, significantly broadening the regulatory scope beyond traditional tobacco-derived nicotine products.